14533438

Source:http://linkedlifedata.com/resource/pubmed/id/14533438

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0003234, umls-concept:C0008838, umls-concept:C0030705, umls-concept:C0040808, umls-concept:C0078257, umls-concept:C0087111, umls-concept:C0246415, umls-concept:C0278488, umls-concept:C0442967
pubmed:issue	4
pubmed:dateCreated	2003-10-9
pubmed:abstractText	To assess the antitumor efficacy and safety of a combination of vinorelbine (VNR) and cisplatin in patients with metastatic breast cancer previously treated with anthracyclines and docetaxel.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8307154
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibiotics, Antineoplastic, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Phytogenic, http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin, http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel, http://linkedlifedata.com/resource/pubmed/chemical/Taxoids, http://linkedlifedata.com/resource/pubmed/chemical/Vinblastine, http://linkedlifedata.com/resource/pubmed/chemical/docetaxel, http://linkedlifedata.com/resource/pubmed/chemical/vinorelbine
pubmed:status	MEDLINE
pubmed:issn	0735-7907
pubmed:author	pubmed-author:BarbounisVV, pubmed-author:DemiriMM, pubmed-author:EfremidisA PAP, pubmed-author:KoumakisGG, pubmed-author:MissitzisJJ, pubmed-author:VassilomanolakisMM
pubmed:issnType	Print
pubmed:volume	21
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	497-504
pubmed:dateRevised	2006-4-24
pubmed:meshHeading	pubmed-meshheading:14533438-Adolescent, pubmed-meshheading:14533438-Adult, pubmed-meshheading:14533438-Aged, pubmed-meshheading:14533438-Antibiotics, Antineoplastic, pubmed-meshheading:14533438-Antineoplastic Agents, Phytogenic, pubmed-meshheading:14533438-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:14533438-Breast Neoplasms, pubmed-meshheading:14533438-Cisplatin, pubmed-meshheading:14533438-Disease Progression, pubmed-meshheading:14533438-Drug Resistance, Neoplasm, pubmed-meshheading:14533438-Female, pubmed-meshheading:14533438-Humans, pubmed-meshheading:14533438-Infusions, Intravenous, pubmed-meshheading:14533438-Male, pubmed-meshheading:14533438-Middle Aged, pubmed-meshheading:14533438-Neoplasm Metastasis, pubmed-meshheading:14533438-Paclitaxel, pubmed-meshheading:14533438-Salvage Therapy, pubmed-meshheading:14533438-Survival Analysis, pubmed-meshheading:14533438-Taxoids, pubmed-meshheading:14533438-Treatment Outcome, pubmed-meshheading:14533438-Vinblastine
pubmed:year	2003
pubmed:articleTitle	Vinorelbine and cisplatin for metastatic breast cancer: a salvage regimen in patients progressing after docetaxel and anthracycline treatment.
pubmed:affiliation	2nd Department of Medical Oncology, St. Savas Oncology Hospital, 171 Alexandra's Ave., Athens 115-22, Greece.
pubmed:publicationType	Journal Article, Clinical Trial